Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis

INTRODUCTION: The long-term benefit–risk profiles of licensed and investigational treatments for moderate-to-severe plaque psoriasis have not been fully characterized. METHODS: Randomized controlled trials (RCTs) of licensed and investigational treatments for moderate-to-severe plaque psoriasis were...

Descripción completa

Detalles Bibliográficos
Autores principales: Armstrong, April W., Soliman, Ahmed M., Betts, Keith A., Wang, Yan, Gao, Yawen, Stakias, Vassilis, Puig, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776931/
https://www.ncbi.nlm.nih.gov/pubmed/34862951
http://dx.doi.org/10.1007/s13555-021-00647-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776931/
https://www.ncbi.nlm.nih.gov/pubmed/34862951
http://dx.doi.org/10.1007/s13555-021-00647-0

Ejemplares similares